|
1
|
Huang XZ, Wang JB and Kong WJ: Practice of
Otorhinolaryngology-Head and Neck Surgery. 2nd. People's Medical
Publishing House; Bei Jing, China: 2007, View Article : Google Scholar
|
|
2
|
Murakami Y, Nobukuni T, Tamura K, Maruyama
T, Sekiya T, Arai Y, Gomyou H, Tanigami A, Ohki M, Cabin D, et al:
Localization of tumor suppressor activity important in nonsmall
cell lung carcinoma on chromosome 11q. Proc Natl Acad Sci USA.
95:8153–8158. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Allinen M, Peri L, Kujala S,
Lahti-Domenici J, Outila K, Karppinen SM, Launonen V and Winqvist
R: Analysis of 11q21-24 loss of heterozygosity candidate target
genes in breast cancer: Indications of TSLC1 promoter
hypermethylation. Genes Chromosomes Cancer. 34:384–389. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fong KM, Kida Y, Zimmerman PV, Ikenaga M
and Smith PJ: Loss of heterozygosity frequently affects chromosome
17q in non-small cell lung cancer. Cancer Res. 55:4268–4272.
1995.PubMed/NCBI
|
|
5
|
Zhou L, Jiang W, Ren C, Yin Z, Feng X, Liu
W, Tao Q and Yao K: Frequent hypermethylation of RASSF1A and TSLC1
and high viral load of Epstein-Barr Virus DNA in nasopharyngeal
carcinoma and matched tumor-adjacent tissues. Neoplasia. 7:809–815.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kuramochi M, Fukuhara H, Nobukuni T, Kanbe
T, Maruyama T, Ghosh HP, Pletcher M, Isomura M, Onizuka M, Kitamura
T, et al: TSLC1 is a tumor suppressor gene in human non-small cell
lung cancer. Nat Genet. 27:427–430. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Murakami Y: Involvement of a cell adhesion
molecule, TSLC1/IGSF4, in human oncogenesis. Cancer Sci.
96:543–552. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fukuhara H, Kuramochi M, Fukami T,
Kasahara K, Furuhata M, Nobukuni T, Maruyama T, Isogai K, Sekiya T,
Shuin T, et al: Promoter methylation of TSLC1 and tumor suppression
by its gene product in human prostate cancer. Jpn J Cancer Res Jun.
93:605–609. 2002. View Article : Google Scholar
|
|
9
|
Jansen M, Fukushima N, Rosty C, Walter K,
Altink R, Heek TV, Hruban R, Offerhaus JG and Goggins M: Aberrant
methylation of the 5′ CpG island of TSLC1 is common in pancreatic
ductal adenocarcinoma and is first manifest in high-grade PanlNs.
Cancer Biol Ther. 1:293–296. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kamen B: Folate and antifolate
pharmacology. Semin Oncol. 24:(5 Suppl 18). S18-30–S18-39.
1997.
|
|
11
|
Friso S and Choi SW: Gene-nutrient
interactions and DNA methylation. J Nutr. 132:(8 Suppl).
2382S–2387S. 2002.PubMed/NCBI
|
|
12
|
Allen RH, Stabler SP, Savage DG and
Lindenbaum J: Metabolic abnormalities in cobalamin (vitamin B12)
and folate deficiency. FASEB J. 7:1344–1353. 1993.PubMed/NCBI
|
|
13
|
Sie KK, Medline A, van Weel J, Sohn KJ,
Choi SW, Croxford R and Kim YI: Effect of maternal and postweaning
folic acid supplementation on colorectal cancer risk in the
offspring. Gut. 60:1687–1694. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jennings BA and Willis G: How folate
metabolism affects colorectal cancer development and treatment; a
story of heterogeneity and pleiotropy. Cancer Lett. 356:224–230.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim YI: Role of folate in colon cancer
development and progression. J Nutr. 133(11): Suppl 1. 3731S–3739S.
2003.PubMed/NCBI
|
|
16
|
Choi SW and Mason JB: Folate status:
Effects on pathways of colorectal carcinogenesis. J Nutr. 132:(8
Suppl). 2413S–2418S. 2002.PubMed/NCBI
|
|
17
|
Kim YI: Folate and carcinogenesis:
Evidence, mechanisms, and implications. J Nutr Biochem. 10:66–88.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuramochi M, Fukuhara H, Nobukuni T, Kanbe
T, Maruyama T, Ghosh HP, Pletcher M, Isomura M, Onizuka M, Kitamura
T, et al: TSLC1 is a tumor-suppressor gene in human non-small-cell
lung cancer. Nat Genet. 27:427–430. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yong M, Yang L, Suyila Q, Han W, Yuan H,
Zhao C and Su X: Expression and clinical implications of P53, P63,
and P73 protein in malignant tumor of the parotid gland. Turk J Med
Sci. 44:875–882. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yurdakul A, Akyurek N, Yilmaz Ş, Karakaya
J, Memİş L and Ozturk C: Prognostic impact of matrix
metalloproteinases (MMP-9 and MMP-2) and vascular endothelial
growth factor expression in non-small cell lung cancer. Turk J Med
Sci. 42:281–288. 2012.
|
|
21
|
Uchino K, Ito A, Wakayama T, Koma Y, Okada
T, Ohbayashi C, Iseki S, Kitamura Y, Tsubota N, Okita Y and Okada
M: Clinical implication and prognostic significance of the tumor
suppressor TSLC1 gene detected in adenocarcinoma of the lung.
Cancer. 98:1002–1007. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Blount BC, Mack MM, Wehr CM, MacGregor JT,
Hiatt RA, Wang G, Wickramasinghe SN, Everson RB and Ames BN: Folate
deficiency causes uracil misincorporation into human DNA and
chromosome breakage: Implications for cancer and neuronal damage.
Proc Natl Acad Sci USA. 94:3290–3295. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Surace EI, Lusis E, Murakami Y,
Scheithauer BW, Perry A and Gutmann DH: Loss of tumor suppressor in
lung cancer-1 (TSLC1) expression in meningioma correlates with
increased malignancy grade and reduced patient survival. J
Neuropathol Exp Neurol. 63:1015–1027. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Steenbergen RD, Kramer D, Braakhuis BJ,
Stern PL, Verheijen RH, Meijer CJ and Snijders PJ: TSLC1 gene
silencing in cervical cancer cell lines and cervical neoplasia. J
Natl Cancer Inst. 96:294–305. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Duthie SJ, Grant G and Narayanan S:
Increased uracil misincorporation in lymphocytes from
folate-deficient rats. Br J Cancer. 83:1532–1537. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Duthie SJ, Narayanan S, Brand GM, Pirie L
and Grant G: Impact of folate deficiency on DNA stability. J Nutr.
132:(8 Suppl). 2444S–2449S. 2002.PubMed/NCBI
|
|
27
|
Butterworth CE Jr: Effect of folate on
cervical cancer. Synergism among risk factors. Ann N Y Acad Sci.
669:293–299. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mason JB and Levesque T: Folate: Effects
on carcinogenesis and the potential for cancer chemoprevention.
Oncology (Williston Park). 10:1727–1736, 1742–1744. 1996.PubMed/NCBI
|
|
29
|
Murakami Y: Functional cloning of a tumor
suppressor gene, TSLC1, in human non-small cell lung cancer.
Oncogene. 21:6936–6948. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fukami T, Fukuhara H, Kuramochi M,
Maruyama T, Isogai K, Sakamoto M, Takamoto S and Murakami Y:
Promoter methylation of the TSLC1 gene in advanced lung tumors and
various cancer cell lines. Int J Cancer. 107:53–59. 2003.
View Article : Google Scholar : PubMed/NCBI
|
